本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Rhythm Pharmaceuticals Inc.

61.74
+0.40000.65%
盘后61.740.00000.00%19:05 EDT
成交量:62.89万
成交额:3,869.78万
市值:39.03亿
市盈率:-14.23
高:61.96
开:61.11
低:60.93
收:61.34
数据加载中...
2025/04/08

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/04/08

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/04/07

重要事件披露

Form 8-K - Current report
2025/03/20

重要事件披露

Form 8-K - Current report
2025/03/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/28

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/02/28

重要事件披露

Form 8-K - Current report
2025/02/28

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/02/26

重要事件披露

Form 8-K - Current report
2025/02/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/10

重要事件披露

Form 8-K - Current report
2024/11/14

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超过5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/11/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/12

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/08

关联方拟减持公告

Form 144 - Report of proposed sale of securities